When a secure dosage has been achieved and affected individual assessment (e.g., urine drug screening) would not point out illicit drug use, considerably less Repeated follow-up visits may very well be ideal; continuation or modification of pharmacotherapy must be determined by the health treatment supplier's analysis of procedure outcomes and obje